A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis Meeting Abstract

  

Authors:	Choo, J.; Saini, J.; Gonzalez-Aguirre, A.; Dahi, P.; Hieronymi, S.; Fernstedt, S.; Tan, K. S.; Adusumilli, P. S.; Ku, G. Y.
Abstract Title:	A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis
Meeting Title:	2025 ASCO Gastrointestinal Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	4 Suppl.
Meeting Dates:	2025 Jan 23-25
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-02-01
DOI:	10.1200/JCO.2025.43.4_suppl.TPS513
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://research.ebsco.com/linkprocessor/plink?id=1fcbfafb-2541-3dee-a1f7-3f6c7a5d21fb
Notes:	Meeting abstract: TPS513 -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222543